Stryker announced that its new Tornier Perform Patient-Matched Primary Reversed Glenoid was used in a surgical procedure for the first time. The case was completed Jan. 13 by Jay Keener, M.D., in St.

Louis and will be highlighted in a presentation at the 2022 Advanced Shoulder Arthroplasty Meeting on Jan. 21 in Snowbird, Utah. The limited-market release Patient-Matched Glenoid is the first surgeon-driven, primary patient-specific implant available in shoulder arthroplasty.

Taking into account the surgeon's surgical preference and patient need, it is a patient-matched implant that is planned on Stryker's Blueprint 3D Planning Software. To generate the Patient-Matched Glenoid, the surgeon uses Blueprint Software to virtually position and execute the creation of a patient-matched implant. Once completed in Blueprint, an order is generated to manufacture the glenoid baseplate and patient-specific instrumentation.

The surgeon will receive the sterile devices and execute the implantation of the baseplate using a ream-free, bone-preserving technique.